Takayasu Arteritis (TAK)
9
3
5
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 9 trials
33%
3 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (9)
Monitoring Disease Activity in Patients With Takayasu Arteritis With the OMERACT Takayasu Ultrasound Score (OTUS)
Global Initiative on Takayasu Arteritis (GITA)
Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis
A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)
Vasculitis Pregnancy Registry
Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis
The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis
Evaluation of Platelet Aggregability in Patients with Takayasu's Arteritis
A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.